Long-Acting ART: Lenacapavir

In this episode, Darcey Wooten, MD, discusses the long-acting HIV treatment agent lenacapavir for treatment-experienced people with HIV, including:

• Efficacy data
• Initiation strategies
• Virologic failure data
• Safety information

Presenter:

Darcy Wooten, MD
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
San Diego, California

To download the slides:
http://bit.ly/3Jb1ofX

To view the full online program:
https://bit.ly/3ZjSFhg

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.